Kim Yun Kyung,Lim Sung Su,Kim Do Hee,Haque Md. Mamunul,Shin Seul Gi,Lee Ha Eun,Kim Tae Hun,Lim Sang Min,Pae Ae Nim
申请号：
US201715697728
公开号：
US9962384(B1)
申请日:
2017.09.07
申请国别(地区):
美国
年份:
2018
代理人:
Rabin & Berdo, P.C.
摘要：
Disclosed is a levosimendan compound, an optically active isomer thereof, or a pharmaceutically acceptable salt thereof, which is used for the prevention and/or treatment of diseases caused by tau aggregation or phosphorylation, such as neurodegenerative diseases (e.g., Alzheimer disease). In accordance with yet another aspect of the present invention, there is provided a health functional food for preventing or treating tau aggregation-related diseases, containing a levosimendan compound or a pharmaceutically acceptable salt, stereoisomer or solvate thereof.
